0.6591
price down icon1.19%   -0.00795
after-market After Hours: .66 0.00095 +0.14%
loading

Hepion Pharmaceuticals Inc Stock (HEPA) Forecast

The Hepion Pharmaceuticals Inc (HEPA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $63.66, representing a +9,560% increase from the current price of $0.6591. The highest analyst price target is $87.06, and the lowest is $40.26.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month HEPA Price Target
Average 43.93 (+6,565% Upside)
loading

Is Hepion Pharmaceuticals Inc (HEPA) A Buy Now?

Oscillators
Name Value Action
RSI(14) 48.04 Neutral
STOCH(9,6) 29.47 Neutral
STOCHRSI(14) 45.53 Neutral
MACD(12,26) -0.00245 Buy
ADX(14) 31.57 Buy
William %R -68.94 Neutral
CCI(14) -20.36 Neutral
Buy: 2 Sell: 0 Neutral: 5
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
0.6975
Sell
0.6727
Sell
MA20
0.6589
Buy
0.6725
Sell
MA50
0.6983
Sell
0.71
Sell
MA100
0.7991
Sell
0.9127
Sell
MA200
1.3378
Sell
1.7854
Sell
Buy: 1 Sell: 9 Neutral: 0
Summary: Sell
According to our latest analysis, HEPA could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 9 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on HEPA, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 48.04 indicates that HEPA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 29.47 indicates that HEPA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 45.53 indicates that HEPA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 31.57 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -20.36 indicates that HEPA is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term HEPA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Hepion Pharmaceuticals Inc financial reports and earnings history, Hepion Pharmaceuticals Inc (HEPA) stock could reach $56.58 by 2030, $18.04 by 2040 and $64.65 by 2050. See the projected annual prices until 2050 of the Hepion Pharmaceuticals Inc stock below:

  • Hepion Pharmaceuticals Inc (HEPA) is expected to reach an average price of $2.499 in 2035, with a high prediction of $3.7602 and a low estimate of $2.799. This indicates an $279.18% rise from the last recorded price of $0.6591.
  • Hepion Pharmaceuticals Inc (HEPA) stock is projected to chart a bullish course in 2040, with an average price target of $18.03, representing an $2,636% surge from its current level. The forecast ranges from a conservative $18.13 to a sky-high $18.04.
  • Our analysts predict Hepion Pharmaceuticals Inc (HEPA) to jump 5,337% by 2045, soaring from $35.78 to an average price of $35.83, potentially reaching $35.94. While $35.78 is the low estimate, the potential upside is significant.
  • Hepion Pharmaceuticals Inc (HEPA) stock is expected to climb by 2050, reaching an average of $62.20, a $9,337% jump from its current level. However, a wide range of estimates exists, with high and low targets of $64.65 and $62.50, respectively, highlighting the market's uncertainty.

Hepion Pharmaceuticals Inc Stock (HEPA) Year by Year Forecast

Hepion Pharmaceuticals Inc Stock (HEPA) Price Forecast for 2024

Our forecast for HEPA stock price in 2024 now indicates an average price target of $57.30 with a high forecast of $114.09 and a low forecast of $0.4996. The average prediction reflects an increase of +8,594% from the last recorded price of $0.6591.
Month Average Low High Change from today's price
December, 2024 $47.86 $40.26 $87.06 +7,161%

Hepion Pharmaceuticals Inc Stock (HEPA) Price Forecast for 2025

Hepion Pharmaceuticals Inc Stock (HEPA) is expected to reach an average price of $27.37 in 2025, with a high prediction of $54.05 and a low estimate of $0.69. This indicates an +4,053% rise from the last recorded price of $0.6591.
Month Average Low High Change from today's price
January, 2025 $12.76 $6.447 $54.05 +1,836%
February, 2025 $17.97 $16.77 $14.47 +2,627%
March, 2025 $14.18 $15.38 $15.78 +2,052%
April, 2025 $4.4001 $11.00 $12.99 +567.64%
May, 2025 $10.69 $0.7905 $19.59 +1,522%
June, 2025 $34.97 $8.9842 $49.98 +5,207%
July, 2025 $19.56 $18.56 $51.57 +2,868%
August, 2025 $24.35 $15.06 $33.35 +3,594%
September, 2025 $22.73 $10.94 $24.13 +3,350%
October, 2025 $17.12 $10.12 $31.33 +2,497%
November, 2025 $9.2943 $9.0911 $18.92 +1,310%
December, 2025 $4.29 $0.69 $14.49 +550.94%

Hepion Pharmaceuticals Inc Stock (HEPA) Price Forecast for 2026

The predicted value for Hepion Pharmaceuticals Inc (HEPA) in 2026 is set at an average of $12.58. Estimates vary from a peak of $24.47 to a trough of $0.6806, indicating an +1,808% surge from the present price of $0.6591.
Month Average Low High Change from today's price
January, 2026 $6.2775 $0.6806 $9.2775 +852.51%
February, 2026 $1.3351 $2.1319 $24.47 +102.57%
March, 2026 $0.9476 $1.4845 $11.46 +43.79%
April, 2026 $2.1633 $0.7508 $3.0492 +228.25%
May, 2026 $1.9759 $4.8759 $3.1476 +199.81%
June, 2026 $10.01 $1.0599 $11.18 +1,419%
July, 2026 $2.4041 $2.4022 $10.41 +264.79%
August, 2026 $4.8167 $4.3073 $3.8187 +630.85%
September, 2026 $0.6324 $1.6261 $4.3708 -4.05%
October, 2026 $2.2449 $1.8418 $1.3614 +240.63%
November, 2026 $0.8575 $1.6512 $1.0543 +30.11%
December, 2026 $6.0732 $2.2606 $3.758 +821.50%

Hepion Pharmaceuticals Inc Stock (HEPA) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Hepion Pharmaceuticals Inc (HEPA) is $6.3105, with a high forecast of $10.89 and a low forecast of $1.736. This indicates an +857.51% increase from the last price of $0.6591.
Month Average Low High Change from today's price
January, 2027 $6.2857 $5.6826 $4.2795 +853.76%
February, 2027 $9.6103 $5.8889 $7.3983 +1,358%
March, 2027 $6.714 $7.5108 $7.7046 +918.74%
April, 2027 $4.5265 $4.9234 $4.9171 +586.83%
May, 2027 $3.5391 $1.736 $1.3391 +437.00%
June, 2027 $10.90 $4.9422 $7.2148 +1,554%
July, 2027 $8.8253 $9.1642 $8.9579 +1,239%
August, 2027 $11.73 $10.16 $9.1819 +1,680%
September, 2027 $11.40 $10.75 $10.89 +1,629%
October, 2027 $8.6042 $8.629 $9.1207 +1,206%
November, 2027 $8.8227 $8.6504 $7.8176 +1,239%
December, 2027 $9.7724 $10.36 $9.6364 +1,383%

Hepion Pharmaceuticals Inc Stock (HEPA) Price Forecast for 2028

In 2028, Hepion Pharmaceuticals Inc (HEPA) is projected to reach an average price of $5.5258, with a high projection of $10.92 and a low estimate of $0.1274. This indicates an +738.44% rise from the last price of $0.6591.
Month Average Low High Change from today's price
January, 2028 $11.25 $8.9607 $9.429 +1,607%
February, 2028 $10.46 $10.86 $10.26 +1,487%
March, 2028 $7.6372 $10.75 $10.92 +1,059%
April, 2028 $1.6938 $2.3898 $7.1705 +157.00%
May, 2028 $2.1645 $0.3008 $2.654 +228.43%
June, 2028 $1.022 $0.1334 $2.4883 +55.07%
July, 2028 $0.6634 $0.1274 $2.2694 +0.66%
August, 2028 $1.9463 $0.1937 $7.9137 +195.31%
September, 2028 $0.2788 $1.6088 $1.3825 -57.69%
October, 2028 $1.1814 $0.492 $1.118 +79.26%
November, 2028 $2.9771 $1.9545 $2.4558 +351.72%
December, 2028 $2.0296 $2.2132 $2.7392 +207.96%

Hepion Pharmaceuticals Inc Stock (HEPA) Price Forecast for 2029

The 2029 price forecast for Hepion Pharmaceuticals Inc Stock (HEPA) is $30.81 on average, with a high prediction of $61.50 and a low estimate of $0.1158. This represents an +4,575% increase from the previous price of $0.6591.
Month Average Low High Change from today's price
January, 2029 $3.8153 $3.4328 $3.4763 +478.91%
February, 2029 $2.9579 $3.0159 $3.0316 +348.81%
March, 2029 $3.7004 $3.271 $3.4773 +461.48%
April, 2029 $2.073 $2.883 $3.2636 +214.54%
May, 2029 $2.9387 $2.4834 $2.3087 +345.90%
June, 2029 $2.7612 $2.7912 $2.6238 +318.97%
July, 2029 $0.3238 $0.4938 $0.8375 -50.87%
August, 2029 $0.0105 $0.2895 $0.6601 -98.41%
September, 2029 $0.3571 $0.1158 $0.3193 -45.82%
October, 2029 $68.30 $0.1852 $61.50 +10,264%
November, 2029 $59.72 $64.12 $60.12 +8,962%
December, 2029 $61.55 $57.21 $59.87 +9,239%

Hepion Pharmaceuticals Inc Stock (HEPA) Price Forecast for 2030

Hepion Pharmaceuticals Inc Stock (HEPA) is expected to reach an average price of $33.06 in 2030, with a high forecast of $64.16 and a low forecast of $1.9641. This signifies an +4,916% surge from the last price of $0.6591.
Month Average Low High Change from today's price
January, 2030 $45.78 $43.37 $56.58 +6,846%
February, 2030 $33.51 $45.39 $42.20 +4,984%
March, 2030 $8.8307 $3.8181 $61.19 +1,240%
April, 2030 $6.6002 $2.4558 $14.76 +901.47%
May, 2030 $2.6872 $1.9641 $36.13 +307.73%
June, 2030 $72.51 $8.2935 $49.51 +10,903%
July, 2030 $66.74 $65.93 $63.24 +10,027%
August, 2030 $62.17 $63.37 $64.16 +9,333%
September, 2030 $57.79 $58.39 $60.78 +8,669%
October, 2030 $35.53 $43.23 $45.21 +5,290%
November, 2030 $10.45 $18.05 $33.23 +1,486%
December, 2030 $12.48 $13.66 $9.7495 +1,793%
$22.32
price down icon 1.11%
$74.12
price up icon 0.26%
$373.97
price up icon 3.48%
$54.36
price down icon 0.66%
$202.64
price down icon 1.63%
$113.10
price down icon 0.74%
Cap:     |  Volume (24h):